CLOSE MENU
Fireside chat and panel will address metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)
September 23, 2024 · 08:00 AM-11:00 AM · Paramount Club, 1301 6th Ave, New York, NY · Register
New York, NY | 19 September 2024- The CUNY Graduate School of Public Health and Health Policy (CUNY SPH) will be among the supporters at a side-event during the United Nations General Assembly (UNGA) week.
The event, “MASLD and MASH: prioritizing a global public health threat,” hosted by the Economist Impact, will focus on metabolic dysfunction-associated steatotic liver disease (MASLD) and its more advanced form, metabolic dysfunction-associated steatohepatitis (MASH), which are highly prevalent, serious yet under-recognized public health threats affecting one in three adults worldwide.
The event will open with a fireside chat with:
- H.E. Hanan Mohamed Al Kuwari, Minister of Public Health, Qatar Ministry of Public Health
- David Kershenobich Stalnikowitz, Director General, National Institute of Medical Sciences and Nutrition Salvador Zubiran
It will then be followed by a panel discussion, in which CUNY SPH Professor of Global Health Dr. Jeffrey V. Lazarus will partake. He will be joined by heads of the World Obesity Federation, Joep Lange Institute, and the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at the Virginia Commonwealth University School of Medicine.
“This event represents a pivotal moment for CUNY SPH to further our commitment to advancing liver health,” says Dr. Lazarus. “There is an urgency to address MASLD and MASH within global public health frameworks, similar to other non-communicable diseases like obesity and type 2 diabetes. Building on the launch of our multi-stakeholder NYC-based health initiative called MASH Cities, this UN side-event will allow us to not only deepen our impact within our communities but also amplify our efforts on an international level. We need to end the MASLD/MASH public health threat here at home in the Big Apple and globally.”
The event has received financial support from CUNY SPH and the CUNY SPH Foundation, alongside Novo Nordisk, Boehringer Ingelheim and Echosens.
Additional information:
This event will invite key stakeholders, including multilateral organizations, policymakers and influencers, civil society and/or patient organizations, and key opinion leaders within MASLD/MASH and other NCDs. It will also examine the socio-economic impacts, explore ways to enhance global awareness, and discuss potential policy measures to end the MASLD/MASH public health threat by 2030.
Following the event, Icahn School of Medicine at Mount Sinai will host a debrief event reception (5-630 PM) alongside the MASH Cities team (a NYC-based health initiative), including Dr. Ayman El- Mohandes (Dean of CUNY SPH), Dr Jeffrey V Lazarus (CUNY SPH) and Dr Meena Bansal (System Chief, Division of Liver Diseases and Director of MASH Center of Excellence, Icahn School of Medicine at Mount Sinai). Attendees can RSVP by emailing Lorraine Clarke-Hewitt at lorraine.clarke-hewitt@mssm.edu before September 21st.
Economist Impact Registration Link: https://shorturl.at/hN35q
Economist Impact Country-specific Policy Briefs: https://shorturl.at/itC1m
Contact information:
For media inquiries or to RSVP, please contact:
Anthony Armenta Jr.
anthony.armentajr@isglobal.org
+34 697 669 094
About CUNY SPH
The CUNY Graduate School of Public Health and Health Policy (CUNY SPH) is committed to promoting and sustaining healthier populations in New York City and around the world through excellence in education, research, and service in public health and by advocating for sound policy and practice to advance social justice and improve health outcomes for all.
About ISGlobal
The Barcelona Institute for Global Health, ISGlobal, is the fruit of an innovative alliance between the ”la Caixa” Foundation and academic and government institutions to contribute to the efforts undertaken by the international community to address the challenges in global health. ISGlobal is a consolidated hub of excellence in research that has grown out of work first started in the world of health care by the Hospital Clínic and the Parc de Salut MAR and in the academic sphere by the University of Barcelona and Pompeu Fabra University. Its working model is based on the generation of scientific knowledge through Research Programa and Groups, and its translation through the areas of Training and Analysis and Global Development. ISGlobal has been named a Severo Ochoa Centre of Excellence and is a member of the CERCA system of the Generalitat de Catalunya.
